 Evofem Biosciences Inc NASDAQ: EVFM achieved preliminary net product sales of 3.5 million in Q4 FY21, more than double in Q3 FY21. During the quarter, 39,121 boxes of Phexxi were dispensed, up 81 from Q3. 